Evidence map›Paper›PMID 41399646›Full record

ArticleTechnical innovations & patient support in radiation oncology2025

Multi-institutional virtual peer review for reirradiation: dedicated workflow and one-year results.

M Ayadi, P Dupuis, M Sandt, G Beldjoudi, A Serre, I Martel-Lafay, L Claude, V Guimas, S Chiavassa, A Moignier and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A dedicated institutional clinical workflow and peer-review meeting for reirradiation.Technical innovations & patient support in radiation oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

M AyadiMedical Physics Department, Centre Léon Bérard, Lyon, France.
P DupuisMedical Physics Department, Centre Léon Bérard, Lyon, France.
M SandtMedical Physics Department, Centre Léon Bérard, Lyon, France.
G BeldjoudiMedical Physics Department, Centre Léon Bérard, Lyon, France.
A SerreRadiation Oncology Department, Centre Léon Bérard, Lyon, France.
I Martel-LafayRadiation Oncology Department, Centre Léon Bérard, Lyon, France.
L ClaudeRadiation Oncology Department, Centre Léon Bérard, Lyon, France.
V GuimasRadiation Oncology Department, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
S ChiavassaDepartment of Medical Physics, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
A MoignierDepartment of Medical Physics, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
A AlexisDepartment of Medical Physics, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
L OllivierRadiation Oncology Department, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
L VaugierRadiation Oncology Department, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
M LangeRadiation Oncology Department, Institut de Cancérologie de l'Ouest, 44805 Saint-Herblain, France.
C MoncharmontRadiation Oncology Department, Centre Léon Bérard, Lyon, France.
M P SunyachRadiation Oncology Department, Centre Léon Bérard, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reports one-year results from multidisciplinary and multi-institutional virtual peer review meetings for reirradiation cases. A dedicated workflow supported collaborative decision-making, especially for complex treatments, and guided dose prescriptions and cumulative dose evaluations. The indication of reRT was disapproved for 19% of the cases, while the reRT dose prescription was suggested or modified for 45% of the validated indications. Results confirm feasibility and clinical value, fostering safer and more standardized reirradiation practices across institutions.

Indexed as

Clinical decision-makingPeer review meetingReirradiation

Identifiers

PMID41399646
PMCPMC12702029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.